gnshealthcare.com

Aitia is a biotech company that harnesses Causal AI, Multi-Omics data, and Gemini Digital Twins to discover the next generation of breakthrough drugs. Their mission is to build the leading AI-enabled biotech company that accelerates the discovery and development of life-saving therapeutics to make a meaningful impact on the lives of patients. Aitia reveals the hidden biological mechanisms of disease with the power of causal AI, multi-omic patient data, and their resulting Gemini Digital Twins.

## How to Use

The website provides information about Aitia's science, partnerships, news, publications, and career opportunities. You can explore their AI-driven pipeline, learn about their team, and view their strategic partnerships. Contact information is also available on the website.

## Key Features

- Causal AI-driven drug discovery - Gemini Digital Twins for disease modeling - Multi-omics patient data analysis - AI-driven pipeline of first-in-kind programs

## Use Cases

- Discovering and developing new drugs for oncology and neurodegenerative diseases - Accelerating the drug discovery process using AI - Identifying hidden biological mechanisms of disease - Creating digital twins of human disease from multi-omic patient data